Patent ID: 9333184
Filing Date: 2016-05-10
CPC Classification: A61K

Claim Text:
1. A method of treating a human male experiencing estrogen dominance comprising the steps of: identifying a level of at least one hormone in the human that is causing the estrogen dominance, wherein the at least one hormone is selected from the group consisting of cortisol, dehydroepiandrosterone sulfate, testosterone, progesterone, and estradiol; providing a composition that comprises between approximately 2.5 mg and 2.7 mg spermine and between approximately 2.5 mg and 2.7 mg spermidine; administering the composition to the human daily for a period of at least thirty days; modifying the level of the at least one hormone in order to decrease production of estrogen in the human; and decreasing progesterone levels in the human after thirty days of treatment.